Cardinal Health, Inc. (CAH)
207.83
-3.09
(-1.46%)
USD |
NYSE |
Mar 20, 16:00
208.95
+1.12
(+0.54%)
Pre-Market: 20:00
Cardinal Health Research and Development Expense (Quarterly) : 0.00 for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Cencora, Inc. | -- |
| McKesson Corp. | -- |
| DaVita, Inc. | -- |
| WEED, Inc. | -- |
| Pineapple, Inc. | -- |